Advanced Biomed Inc.

ADVB Healthcare Diagnostics & Research

Advanced Biomed Inc.’s revenue for fiscal 2026 (year ended June 2026) was $127,600.00. In the quarter to June 2026, EPS grew 54.8% and free cash flow fell 101.3%, each against the same quarter a year earlier.

3.98 0.90 −18.44%
Market cap
$8.1M
P/E
0.8×
Fwd P/E
—
Dividend yield
—
F-score
n/a
Altman Z
0.68
Beneish M
n/a
Dividend safety
n/a
Older periods Sep '25 Dec '25 Mar '26 Jun '26
Current Ratio

+7 more quarters

1.92 8.56 7.38 9.33
Net Debt/EBITDA
5.58 6.36 5.10 0.08
Debt/Equity
0.00 0.00 0.00 0.00
Free Cash Flow per Share
(0.57) (0.49) (0.19) (2.51)
Book value per Share
2.78 8.76 7.17 9.80
Free Cash Flow
(0.61) (0.53) (0.24) (3.15)
Other line items

Show all line items

Columns are period end dates · fundamentals updated 15 Oct 2026